QSAR of HIV-1 integrase inhibitors by genetic function approximation method

被引:26
作者
Makhija, MT [1 ]
Kulkarni, VM [1 ]
机构
[1] Univ Bombay, Dept Chem Technol, Pharmaceut Div, Bombay 400019, Maharashtra, India
关键词
D O I
10.1016/S0968-0896(01)00415-1
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Quantitative structure-activity relationship (QSAR) paradigm, using genetic function approximation (GFA) technique was used to examine the correlations between the calculated physicochemical descriptors and the in vitro activities Q-processing and 3'-strand transfer inhibition) of a series of human immunodeficiency virus type 1 (HIV-1) integrase inhibitors. Depending on the chemical structure. all molecules were divided into two classes-catechols and noncatechols. Eighty-one molecules were used in the present study and they were divided into training set and test set. The training set in each class consisted of 35 molecules and QSAR models were generated separately for both catechols and noncatechols. Equations were evaluated using internal as well as external test set predictions. Models generated for catechols show that electronic, shape related, and thermodynamic parameters are important whereas for noncatechols, spatial, structural, and thermodynamic properties play an important role for the activity. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:1483 / 1497
页数:15
相关论文
共 34 条
[1]   Identification of HIV-1 integrase inhibitors via three-dimensional database searching using ASV and HIV-1 integrases as targets [J].
Chen, IJ ;
Neamati, N ;
Nicklaus, MC ;
Orr, A ;
Anderson, L ;
Barchi, JJ ;
Kelley, JA ;
Pommier, Y ;
MacKerell, AD .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (10) :2385-2398
[2]   HOTSPOTS AND WARM SPOTS - INTEGRATION SPECIFICITY OF RETROELEMENTS [J].
CRAIGIE, R .
TRENDS IN GENETICS, 1992, 8 (06) :187-190
[3]   CROSS-VALIDATION, BOOTSTRAPPING, AND PARTIAL LEAST-SQUARES COMPARED WITH MULTIPLE-REGRESSION IN CONVENTIONAL QSAR STUDIES [J].
CRAMER, RD ;
BUNCE, JD ;
PATTERSON, DE ;
FRANK, IE .
QUANTITATIVE STRUCTURE-ACTIVITY RELATIONSHIPS, 1988, 7 (01) :18-25
[4]  
GOFF SP, 1992, ANNU REV GENET, V26, P527, DOI 10.1146/annurev.ge.26.120192.002523
[5]   Understanding the antifungal activity of terbinafine analogues using quantitative structure-activity relationship (QSAR) models [J].
Gokhale, VM ;
Kulkarni, VM .
BIOORGANIC & MEDICINAL CHEMISTRY, 2000, 8 (10) :2487-2499
[6]   Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: A platform for antiviral drug design [J].
Goldgur, Y ;
Craigie, R ;
Cohen, GH ;
Fujiwara, T ;
Yoshinaga, T ;
Fujishita, T ;
Sugimoto, H ;
Endo, T ;
Murai, H ;
Davies, DR .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (23) :13040-13043
[7]   RECEPTOR SURFACE MODELS .2. APPLICATION TO QUANTITATIVE STRUCTURE-ACTIVITY-RELATIONSHIPS STUDIES [J].
HAHN, M ;
ROGERS, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1995, 38 (12) :2091-2102
[8]  
Hariprasad V., 1998, Pharmacy and Pharmacology Communications, V4, P365
[10]  
KATZ RA, 1994, ANNU REV BIOCHEM, V63, P137